SenAI Intelligence Secures $8.3M Series A Funding Led by Sequoia China with Strategic Investment from CEC Health Fund
SYNYI AI
Provider of Comprehensive Solutions for Medical Big Data
Recently, VCBeat learned that SYNYI·AI, which focuses on medical data governance and artificial intelligence applications, announced the completion of its 55 million RMB Series A financing.This round of financing was led by Sequoia Capital China, with strategic investment from CEC Health Fund.Among them, the CEC Health Fund was initiated and established by China Electronics Data Service Co., Ltd. (hereinafter referred to as “CEC Data”) to cultivate an industrial ecosystem for health and medical big data.
SYNYI·AI’s current round of financing was exclusively advised by China Renaissance Alpha as the sole financial advisor. Upon the completion of this funding round, SYNYI·AI will continue to strengthen its technological advantages in medical natural language processing, healthcare data governance, and machine learning; expand its team and business operations; and sustain investments in product research and development as well as participation in the formulation of industry standards and specifications.
According to the VCBeat database, in January 2017, SYNYI·AI secured an angel round of financing amounting to nearly RMB 10 million, led by ZhenFund and participated in by Huayan Capital and Shulan Healthcare.
SYNYI·AI, established in April 2016 and headquartered in Shanghai, is dedicated to building a world-class artificial intelligence platform and applications for healthcare. By leveraging AI technologies, the company aims to address the challenges faced by medical institutions, including poor quality of medical data, insufficient structuring and standardization, and the fragmentation of data into isolated “silos” that hinder effective utilization.
Transform low-value data into high-quality data through data governance, driving AI applications for medical research, clinical management, and patient services, and accelerating the development of intelligent healthcare systems.
Dr. Zhang Shaodian, Founder and CEO of SYNYI·AI, earned his Ph.D. in Biomedical Informatics from Columbia University in the United States. In addition to serving as CEO of SYNYI·AI, he holds an adjunct position as a Distinguished Researcher at the APEX Data and Knowledge Management Laboratory within the Department of Computer Science and Engineering at Shanghai Jiao Tong University. He has published dozens of international academic papers in the fields of biomedical informatics and healthcare data, establishing himself as one of the leading young academics driving research and translational outcomes in medical data mining and medical natural language processing.
SYNYI·AI’s products and services currently cover dozens of tertiary hospitals in China, and the company has established R&D collaborations with renowned domestic and international universities, including Peking University, Shanghai Jiao Tong University, Fudan University, Cornell University, and Columbia University. It strives to achieve world-class excellence in the standardized governance of medical data and artificial intelligence applications, thereby establishing professional clinical industry standards tailored to the characteristics of China’s medical data.
Meanwhile,In June 2017, SYNYI·AI signed a strategic cooperation agreement with CEC Data. As the national team in the development of the health and medical big data industry, CEC Data is a professional platform company under China Electronics Corporation (CEC) that implements the national strategy for big data in healthcare. It actively deploys resources in the health and medical big data sector, providing data integration, management, and application services to key national industries, departments, and enterprises. As its core technology provider, SYNYI·AI is responsible for regional-level medical data governance and AI modeling.。
SYNYI·AI’s initial core product is a fully self-developed artificial intelligence algorithm for automated analysis of medical texts, which enables machines to interpret medical records with the same proficiency as physicians and rapidly convert unstructured text-based records into structured data; its speed in processing medical records is 98% faster than that of doctors.
Through this technology, SYNYI·AI helps hospitals build data platforms to integrate, organize, and enhance the value of massive amounts of raw data within medical institutions. Based on the organized data, SYNYI·AI also assists hospitals in deploying a series of AI applications—including intelligent patient management, intelligent clinical research, intelligent operational quality control, intelligent diagnosis and treatment, and clinical decision support—unlocking significant market potential.
We believe that AI applications will first surge in industries with rich data accumulation. The massive amount of raw medical record text data held by hospitals provides fertile ground for AI applications, while standardized data governance is an indispensable first step.
We are highly optimistic about SYNYI·AI’s robust technological accumulation in the field of medical AI applications. Dr. Zhang Shaodian, founder of SYNYI·AI, brings deep industry insights and forward-looking judgment that will help the company grow more rapidly into a next-generation, platform-level medical artificial intelligence enterprise.
——Investor in SYNYI·AI
Yin Le, Investment Manager at ZhenFund
To learn more about SYNYI·AI, please click on “【[Exclusive] Securing Nearly RMB 10 Million in Series A Funding, SYNYI·AI Leverages AI to Structure Medical Data for Secondary Applications》